Actual Medicinal Product (AMP) - Rimmyrah 2.3mg/0.23ml solution for injection vials (Orion Pharma (UK) Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Rimmyrah 2.3mg/0.23ml solution for injection vials | Start Date 01-08-2024 | End Date |
Summary
- Licensed Route
- Intravitreal
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 43132411000001103 | 01-08-2024 |
Parent Products
-
VTMRanibizumab
-
VMPRanibizumab 2.3mg/0.23ml solution for injection...
-
AMP(Current) Rimmyrah 2.3mg/0.23ml solution... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 1 vial | 52345 |